Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Surgical Wound Infection 4Colorectal Neoplasms 4Neoplasms 3Sepsis 2Pancreatic Neoplasms 2Leukemia, Myeloid, Acute 2Febrile Neutropenia 2Triple Negative Breast Neoplasms 1Solitary Pulmonary Nodule 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Fistula 1Neutropenia 1Neoplasms, Plasma Cell 1Multiple Pulmonary Nodules 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lung Neoplasms 1Intestinal Neoplasms 1Inflammation 1Infections 1Glioblastoma 1Fever 1Exanthema 1Emergencies 1Duodenal Neoplasms 1Discitis 1Diarrhea 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 177Radiotherapy 139Cisplatin 110Pemetrexed 102Docetaxel 93Paclitaxel 92Gemcitabine 78Erlotinib Hydrochloride 73Magnetic Resonance Spectroscopy 72Radiosurgery 67Bevacizumab 65pembrolizumab 64Etoposide 60Blood Specimen Collection 60durvalumab 53Specimen Handling 48Nivolumab 48Surveys and Questionnaires 47Drug Therapy 41Standard of Care 35Radiation 33osimertinib 32atezolizumab 32Surgical Procedures, Operative 30Topotecan 29Irinotecan 29Gefitinib 29Educational Status 29Early Intervention, Educational 29Biopsy 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lung Neoplasms × Anti-Bacterial Agents × Clear all
NCT05502913 2023-10-02

Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer

Soroka University Medical Center

Phase 2 Recruiting
80 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡